Angiotensin-converting enzyme inhibitor-induced angioedema and hereditary angioedema: A comparison study of attack severity

Internal Medicine

Volumn 54, Issue 20, 2015, Pages 2583-2588

  Javaud, Nicolas ^a,b   Charpentier, Stéphane ^a   Lapostolle, Frédéric ^b   Lekouara, Hakim ^a   Boubaya, Marouane ^b   Lenoir, Gilles ^a   Mekinian, Arsène ^a   Adnet, Frédéric ^a,b   Fain, Olivier ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

ACE I AE; Bradykinin; Emergency; Hereditary angioedema

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; TRANEXAMIC ACID; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ANGIOTENSIN CONVERTING ENZYME INHIBITOR INDUCED ANGIOEDEMA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENDOTRACHEAL INTUBATION; FACIAL SWELLING; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL EDEMA; RETROSPECTIVE STUDY; SWELLING; TONGUE SWELLING; TRACHEOTOMY; AGED; ANGIOEDEMA; ANGIOEDEMAS, HEREDITARY; CHEMICALLY INDUCED; DRUG EFFECTS; LARYNX; LIP; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TONGUE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; ANGIOEDEMAS, HEREDITARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LARYNX; LIP; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TONGUE; YOUNG ADULT;

EID: 84944459358     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.4181     Document Type: Article

References (26)

1. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet 351: 1693-1697, 1998.
2. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 347: 621-622, 2002.
3. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin converting enzyme inhibitor--associated angioedema. JAMA 278: 232-233, 1997.
4. Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 379: 474-481, 2012.
5. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 164: 910-913, 2004.
6. Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56: 278-282, 2010.
7. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6: 24, 2010.
8. Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykininreceptor antagonist, in hereditary angioedema. N Engl J Med 363: 532-541, 2010.
9. Craig TJ, Bewtra AK, Bahna SL, et al. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks: final results of the I.M.P.A.C.T.2 study. Allergy 66: 1604-1611, 2011.
10. Nielsen EW, Gramstad S. Angioedema from angiotensinconverting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50: 120-122, 2006.
11. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100: 327-332, 2008.
12. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M. Long-term follow-up of 111 patients with angiotensinconverting enzyme inhibitor-related angioedema. J Hypertens 29: 2273-2277, 2011.
13. Bluestein HM, Hoover TA, Banerji AS, Camargo CA Jr, Reshef A, Herscu P. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol 103: 502-507, 2009.
14. Campbell T, Peckler B, Hackstadt RD, Payor A. ACE inhibitorinduced angioedema of the bowel. Case Rep Med 2010: 690-695, 2010.
15. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119: 267-274, 2006.
16. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 4: e297, 2007.
17. Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 6: 15, 2010.
18. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356: 213-217, 2000.
19. Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol 6: 14, 2010.
20. Vitrat-Hincky V, Gompel A, Dumestre-Perard C, et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 65: 1331-1336, 2010.
21. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165: 1637-1642, 2005.
22. Roberts JR, Lee JJ, Marthers DA. Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol 109: 774-775, 2012.
23. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 163: 1229-1235, 2003.
24. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 130: 692-697, 2012.
25. Javaud N, Karami A, Stirnemann J, et al. Bradykinin-mediated angioedema: factors prompting ED visits. Am J Emerge Med 31: 124-129, 2013.
26. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 46: 1239-1243, 2001.